Experts predict over the next two years, life sciences companies will invest over $3 billion in AI, with two-thirds adopting the "intelligent lab of the future" within four years.

Taking a digital-first approach has become a strategic imperative in the pharmaceutical and biopharma industries. Yet many life sciences companies, big and small, are early in their digital transformation journeys or not yet gleaning value from their existing investments.

Enthought has been digitally transforming R&D for leading, global science-driven companies for over 20 years. We're providing this eBook to help guide your lab's transformation initiatives.

Download “The Lab of the Future: Five Barriers to Digital Transformation in the Life Sciences Industry” to learn:

• How current industry-specific market trends and pressures are impacting decisions
• The common barriers to successful digital transformation in life sciences
• Recommendations on what can be done now to attain the future-proofed R&D lab
  
  

Questions? Contact info@enthought.com to discuss how the Enthought Materials Science and Chemistry Solutions Group can help future-proof your R&D lab and accelerate your business.

Click here to explore our resources page for more in-depth case studies, whitepapers, ebooks,and more.